comparemela.com

Page 6 - Nasdaq Moln News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Molecular Partners Announces Research Collaboration with

Research collaboration with leading acute myeloid leukemia (AML) experts, Professor Ochsenbein and Professor Riether from the Department of Medical.

Nicolas leupinAdrian ochsenbeinCarsten rietherDepartment of medical oncologyExchange commissionUniversity of bernBern university hospitalCompany darpinProfessor ochsenbeinProfessor rietherMedical oncologyMolecular partnerNaegeli prizeMolecular partnersPartnert cellNote regarding forward looking statements

Molecular Partners to Host Oncology Day (Virtual)

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 15, 2021 (GLOBE NEWSWIRE) Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage.

Anne goubierNicolas leupinMichael stumppPatrick amstutzDaniel steinerAdrian ochsenbeinCarsten rietherParticipant international dialBern university hospitalSenior managementFibroblast activation proteinBern universityOncology dayToll free dial in numberInternational dial in numberNasdaq moln

Molecular Partners Confirms Ensovibep Retains

Laboratory studies using full Omicron pseudovirus confirm ensovibep maintains ability to neutralize the variant with very high potency, relative to.

United statesPatrick amstutzNational institutes of healthCentre hospitalier universitaire vaudoisNational institutesMolecular partnersNasdaq molnMolecular partners

Molecular Partners Presents Results from a Phase 2a Trial

First presentation of data from patients treated with ensovibep demonstrate the candidate to be safe and well-tolerated All patients exhibited reductions.

Patrick amstutzLutz hegemannMarianne soergelDepartment of infectious diseasesCentre for human drug researchGlobal health for novartisLeiden university medical centerEuropean scientific working group on influenzaGroup head of corporate affairsEuropean scientific working groupHuman drug researchGroup headCorporate affairsGlobal healthMolecular partnerMolecular partners

vimarsana © 2020. All Rights Reserved.